These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9601889)

  • 1. [Personal experience in the diagnosis and monitoring of therapy in metabolic disorders with risk of crystallization in patients with recurrent urolithiasis].
    Stejskal D; Bártek J; Hrebícek J; Bána J; Zát'ura F; Mohapl P; Terber R
    Vnitr Lek; 1997 Dec; 43(12):781-6. PubMed ID: 9601889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R; Czkwianianc E; Niedworok M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of metabolic disorders as a cause of urolithiasis in clinical practice].
    Kocvara R; Louzenský G; Ptácek V
    Cas Lek Cesk; 1989 Mar; 128(10):295-8. PubMed ID: 2720728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of calcium sodium citrate supplementation of a test meal on mineral homeostasis, oxalate, and calcium oxalate crystallization in the urine of healthy humans--preliminary results in patients with idiopathic calcium urolithiasis.
    Herrmann U; Schwille PO; Schmiedl A; Fan J; Manoharan M
    Biomed Pharmacother; 1999 Jun; 53(5-6):264-73. PubMed ID: 10424248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
    Hamid R; Robertson WG; Woodhouse CR
    BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urolithiasis in adults. Clinical and biochemical aspects.
    Abdel-Halim RE
    Saudi Med J; 2005 May; 26(5):705-13. PubMed ID: 15951854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of mineral water TIB-2 on metabolic processes in urolithiasis patients].
    Dzeranov NK; Beshliev DA; Golovanov SA; Kon'kova TA
    Urologiia; 2000; (3):15-7. PubMed ID: 11186701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age of onset of urolithiasis: relation to clinical and metabolic risk factors].
    Lancina Martín JA; Novás Castro S; Rodríguez-Rivera García J; Ruibal Moldes M; Blanco Díez A; Fernández Rosado E; Barbagelata López A; González Martín M
    Arch Esp Urol; 2004 Mar; 57(2):119-25. PubMed ID: 15074780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metaphylaxis of urolithiasis, methods and results].
    Kocvara R; Ptácek V; Tuíková J; Louzenský G; Koblízková L
    Cas Lek Cesk; 1989 Feb; 128(9):266-9. PubMed ID: 2743387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine fetuin-A values in relation to the presence of urolithiasis.
    Stejskal D; Karpisek M; Vrtal R; Student V; Solichova P; Fiala R; Stejskal P
    BJU Int; 2008 May; 101(9):1151-4. PubMed ID: 18190622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extended metabolic diagnosis of urolithiasis].
    Laube N; Bradenahl J; Thomas E; Meissner A; Müller SC
    Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metaphylaxis in the first occurrence of urolithiasis].
    Kocvara R; Plasgura P; Petrík A; Louzenský G; Bartonícková K
    Cas Lek Cesk; 2000 Dec; 139 Suppl 1():16-8. PubMed ID: 11262895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of dynamic observation in the prevention of recurrences of stone formation].
    Dzeranov NK; Darenkov AF; Konstantinova OV; Beshliev DA; Borisik VI; Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1998; (2):12-4. PubMed ID: 9577694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal management of urolithiasis in renal transplantation.
    Challacombe B; Dasgupta P; Tiptaft R; Glass J; Koffman G; Goldsmith D; Khan MS
    BJU Int; 2005 Aug; 96(3):385-9. PubMed ID: 16042735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrence-free and recurrent urolithiasis: metabolic differences].
    Konstantinova OV; Ianenko EK; Dzeranov NK
    Urologiia; 1999; (5):8-9. PubMed ID: 11150160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.